Perturbed cell signaling network and suicide neurobiology

扰动的细胞信号网络和自杀神经生物学

基本信息

  • 批准号:
    8908050
  • 负责人:
  • 金额:
    $ 33.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-12 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Suicide is a major public health concern. Suicidal behavior occurs in the context of a diathesis that is characterized by traits in multiple domains: behavioral, clinical, personality, and biologic. While the complexity of suicidal behavior requires a multi-faceted prevention approach, the identification of neurobiological dysfunction is critical for the pharmacological interventions that may have protective effects against suicidal behavior. In this context, we have shown reduced BDNF gene expression and less activation of its cognate receptor TrkB in the brain of suicide subjects. In addition, we have found that p75NTR, a low affinity BDNF receptor is upregulated in the brain of these subjects. BDNF, which plays a critical role in neural plasticity and cell survival, essentially mediates its action via TrkB-mediated activation of extracellular signal-regulated kinase (ERK)1/2 and phosphoinositide 3 kinase (PI3K) signaling pathways. Abnormalities in these two signaling systems at the upstream levels were also found in the same brain areas of suicide subjects in which abnormalities were noted in BDNF/TRKB/p75NTR. These changes were present in all suicide subjects regardless of psychiatric diagnosis. To better understand the functional significance of altered BDNF signaling at molecular and cellular levels and their implications in the neurobiology of suicide, we propose to test the hypothesis that hypoactive BDNF/TrkB-mediated ERK1/2 and PI3K/Akt and overexpressed p75NTR will lead to modifications in the interaction and activation of downstream scaffolding/regulatory proteins, translational machinery, chromatin remodeling, and structural plasticity in the suicide brain. To test our hypothesis, in brain areas implicated in suicidal behavior, i.e., dlPFC and hippocampus (cerebellum as negative control brain region) from well-characterized and well-matched depressed suicide and non-psychiatric control subjects (n = 30 in each group), we aim to examine whether: 1) hypoactive ERK1/2 will lead to altered activation of substrates p90 ribosomal S6 kinase (RSK) and mitogen- and stress-activated kinase (MSK) and their mediated transactivation of transcription factors and chromatin remodeling; 2) hypoactive ERK1/2 and PI3K will lead to less active translational machinery, translation of postsynaptic genes, and altered dendritic morphology; and 3) altered PI3K/Akt and p75NTR will be associated with altered interactions of scaffolding proteins leading to c-Jun kinase (JNK) activation and altered expression and functional characteristics of downstream apoptotic regulatory proteins and neuronal apoptosis. To make sure that the effects are suicide specific, we will perform these studies in the same brain areas of an additional group of well-matched subjects who were depressed (no previous suicide attempt and no family history of suicide) and died by causes other than suicide (n = 30). Our proposed study will precisely and mechanistically assess the complexity of cellular signaling at the molecular, cellular, and functional levels in suicide brain and will have a significant impact in understanding not only the neurobiological basis of suicide but in designing more efficacious treatment strategies.
描述(由申请人提供):自杀是一个主要的公共卫生问题。自杀行为发生在具有多个领域特征的背景下:行为、临床、人格和生物学。虽然自杀行为的复杂性需要 作为一种多方面的预防方法,神经生物学功能障碍的识别对于可能对自杀行为产生保护作用的药物干预至关重要。在这种情况下,我们发现自杀受试者大脑中 BDNF 基因表达减少,其同源受体 TrkB 激活减少。此外,我们发现 p75NTR(一种低亲和力 BDNF 受体)在这些受试者的大脑中表达上调。 BDNF 在神经可塑性和细胞存活中发挥着关键作用,主要通过 TrkB 介导的细胞外信号调节激酶 (ERK)1/2 和磷酸肌醇 3 激酶 (PI3K) 信号通路的激活来介导其作用。在自杀受试者的相同大脑区域中也发现了上游水平的这两个信号系统的异常,其中 BDNF/TRKB/p75NTR 出现异常。无论精神病学诊断如何,所有自杀受试者都存在这些变化。为了更好地理解分子和细胞水平上 BDNF 信号传导改变的功能意义及其对自杀神经生物学的影响,我们建议检验以下假设:BDNF/TrkB 介导的 ERK1/2 和 PI3K/Akt 活性低下以及 p75NTR 过度表达将导致自杀自杀大脑中下游支架/调节蛋白的相互作用和激活、翻译机制、染色质重塑和结构可塑性的改变。为了检验我们的假设,在与自杀行为有关的大脑区域,即 dlPFC 和海马体(小脑作为阴性对照大脑区域),来自特征明确且匹配良好的抑郁症自杀者和非精神病对照受试者(每组 n = 30) ,我们的目的是检查:1) ERK1/2 活性低下是否会导致底物 p90 核糖体 S6 激酶 (RSK) 的激活发生改变,以及丝裂原激活激酶和应激激活激酶 (MSK) 及其介导的转录因子反式激活和染色质重塑; 2)ERK1/2和PI3K活性低下将导致翻译机制、突触后基因翻译和树突形态改变的活性降低; 3) PI3K/Akt 和 p75NTR 的改变与支架蛋白相互作用的改变有关,导致 c-Jun 激酶 (JNK) 激活,并改变下游凋亡调节蛋白和神经元凋亡的表达和功能特征。为了确保效果是针对自杀的,我们将在另一组匹配良好的受试者的相同大脑区域中进行这些研究,这些受试者患有抑郁症(以前没有自杀企图,也没有自杀家族史),并且死于除以下原因之外的原因:自杀(n = 30)。我们提出的研究将在分子、细胞和功能水平上精确地、机械地评估自杀大脑中细胞信号传导的复杂性,并将对理解自杀大脑产生重大影响。 自杀的神经生物学基础,但设计更有效的治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yogesh Dwivedi其他文献

Yogesh Dwivedi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yogesh Dwivedi', 18)}}的其他基金

Predoctoral Training in Multifaceted Translational Approach to Mental Illness
精神疾病多方面转化方法的博士前培训
  • 批准号:
    10628129
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
神经源性血浆外泌体 MicroRNA 作为青少年自杀和治疗结果的有前景的新型生物标志物
  • 批准号:
    10684830
  • 财政年份:
    2022
  • 资助金额:
    $ 33.08万
  • 项目类别:
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
神经源性血浆外泌体 MicroRNA 作为青少年自杀和治疗结果的有前景的新型生物标志物
  • 批准号:
    10684830
  • 财政年份:
    2022
  • 资助金额:
    $ 33.08万
  • 项目类别:
Novel regulatory role of nuclear miRNAs in repatterning the transcriptional and post-transcriptional dynamics in MDD brain
核 miRNA 在重模式 MDD 大脑转录和转录后动态中的新调节作用
  • 批准号:
    10661760
  • 财政年份:
    2022
  • 资助金额:
    $ 33.08万
  • 项目类别:
MicroRNA Correlates of Childhood Maltreatment and Suicidality
MicroRNA 与童年虐待和自杀的相关性
  • 批准号:
    10394212
  • 财政年份:
    2021
  • 资助金额:
    $ 33.08万
  • 项目类别:
MicroRNA Correlates of Childhood Maltreatment and Suicidality
MicroRNA 与童年虐待和自杀的相关性
  • 批准号:
    10642884
  • 财政年份:
    2021
  • 资助金额:
    $ 33.08万
  • 项目类别:
Epitranscriptomic Mapping of Novel N6-Adenosine-based RNA Methylation in MDD Brain
MDD 脑中新型 N6-腺苷 RNA 甲基化的表观转录组图谱
  • 批准号:
    9978955
  • 财政年份:
    2019
  • 资助金额:
    $ 33.08万
  • 项目类别:
Epitranscriptomic Mapping of Novel N6-Adenosine-based RNA Methylation in MDD Brain
MDD 脑中新型 N6-腺苷 RNA 甲基化的表观转录组图谱
  • 批准号:
    10402779
  • 财政年份:
    2019
  • 资助金额:
    $ 33.08万
  • 项目类别:
Epitranscriptomic Mapping of Novel N6-Adenosine-based RNA Methylation in MDD Brain
MDD 脑中新型 N6-腺苷 RNA 甲基化的表观转录组图谱
  • 批准号:
    10616780
  • 财政年份:
    2019
  • 资助金额:
    $ 33.08万
  • 项目类别:
MicroRNA Mapping in Major Depression
重度抑郁症中的 MicroRNA 作图
  • 批准号:
    8647464
  • 财政年份:
    2014
  • 资助金额:
    $ 33.08万
  • 项目类别:

相似国自然基金

组蛋白乳酸化激活ac4C乙酰化促进葡萄膜黑色素瘤发展的作用机制研究
  • 批准号:
    82373298
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
IDF代谢产物异丁酸通过促进H2AK5和H2BK12乙酰化修饰调控c-Myc影响NSCLC的分子机制及流行病学研究
  • 批准号:
    82304235
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肠道菌群短链脂肪酸代谢物通过组蛋白去乙酰化酶HDAC2/ELK1通路调控模拟失重下成骨细胞分化和骨形成的机制研究
  • 批准号:
    82302112
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于组蛋白去乙酰化酶调控策略挖掘海洋真菌SX7S7中隐性次级代谢产物及其调控机制研究
  • 批准号:
    32300070
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
组蛋白去乙酰化酶CsHDA6参与调控茶尺蠖侵害诱导茶叶产生α-法尼烯的分子机制
  • 批准号:
    32302356
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
Domain- and protein-selective BET mechanisms in cocaine-seeking behaviors
可卡因寻求行为中的结构域和蛋白质选择性 BET 机制
  • 批准号:
    10714343
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
Restore the Tumor-Suppressive Activities of p53 Mutants
恢复 p53 突变体的肿瘤抑制活性
  • 批准号:
    10716397
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
Configuration-specific cofactors of Oct4
Oct4 的配置特定辅因子
  • 批准号:
    10713592
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 33.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了